Nonsteroidal Anti-Inflammatory Drugs Not Linked to Major Congenital Malformations
Medically reviewed by Drugs.com
via HealthDayTHURSDAY, May 14, 2026 -- There is no evidence of an association between first-trimester exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) and major congenital malformations (MCMs), according to a study published online May 14 in PLOS Medicine.
Ariel Avraham Hasidim, from Ben-Gurion University of the Negev in Be'er-Sheva, Israel, and colleagues evaluated the association between first-trimester NSAID exposure and the risk for MCMs among 264,858 singleton pregnancies (20,202 exposed-to-NSAID pregnancies) in a retrospective register-based cohort study.
The researchers found the most commonly used NSAIDs were ibuprofen (5.1 percent), diclofenac (1.6 percent), and naproxen (1.2 percent). As a class and for individual NSAIDs, there was no association for MCMs overall (8.2 versus 7.0 percent; matched-adjusted-relative risk [aRR], 0.99) or with organ system-specific MCMs, including cardiovascular (matched-aRR, 1.05), musculoskeletal (matched-aRR, 1.03), central nervous system (matched-aRR, 0.77), cleft palate (matched-aRR, 0.95), gastrointestinal (matched-aRR, 1.03), and genitourinary (matched-aRR, 0.99) malformations. Additionally, there were no significant dose-response associations with MCMs across cumulative NSAID exposure: short term (one to seven defined-daily-dose [DDD]: matched-aRR, 1.06), medium term (eight to 21 DDD: matched-aRR, 1.10), and long-term (>21 DDD: matched-aRR, 1.24).
"Our results provide reassuring evidence that NSAID use in early pregnancy is not associated with major birth defects," the authors write. "These findings can help both pregnant women and physicians make informed decisions about managing pain and fever in early pregnancy."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-15 09:45
Read more
- Prevalence of Autism Spectrum Disorder Elevated in Children With Epilepsy
- Cumberland Pharmaceuticals Announces Expanded Indication for Caldolor (ibuprofen) Injection
- Regaining Weight After Quitting Your GLP-1 Drug? A Simple Procedure Might Help, Study Says
- Online Program Soothes Post-Trauma Stress In Injured Children
- One-Year Mortality 8.6 Percent After ED Visit for Opioid Overdose
- Boehringer Ingelheim’s Novel Glucagon/GLP-1 Dual Agonist Survodutide Achieved Significant Weight Loss and Meaningful Metabolic Improvement in Phase III Trial
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions